Verrica Pharmaceuticals, Inc. (VRCA)
4.11
-0.07
(-1.67%)
USD |
NASDAQ |
Oct 09, 16:00
4.10
-0.01
(-0.24%)
After-Hours: 20:00
Verrica Pharmaceuticals Total Liabilities (Quarterly) : 31.71M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.71M |
| March 31, 2026 | 22.73M |
| December 31, 2025 | 22.78M |
| September 30, 2025 | 57.94M |
| June 30, 2025 | 56.59M |
| March 31, 2025 | 60.75M |
| December 31, 2024 | 64.48M |
| September 30, 2024 | 66.98M |
| June 30, 2024 | 65.31M |
| March 31, 2024 | 64.80M |
| December 31, 2023 | 61.83M |
| September 30, 2023 | 54.84M |
| June 30, 2023 | 6.801M |
| March 31, 2023 | 3.793M |
| December 31, 2022 | 4.688M |
| September 30, 2022 | 4.382M |
| June 30, 2022 | 47.10M |
| March 31, 2022 | 46.20M |
| Date | Value |
|---|---|
| December 31, 2021 | 47.52M |
| September 30, 2021 | 47.90M |
| June 30, 2021 | 46.87M |
| March 31, 2021 | 46.29M |
| December 31, 2020 | 41.17M |
| September 30, 2020 | 40.75M |
| June 30, 2020 | 38.77M |
| March 31, 2020 | 37.83M |
| December 31, 2019 | 3.409M |
| September 30, 2019 | 4.421M |
| June 30, 2019 | 4.405M |
| March 31, 2019 | 3.218M |
| December 31, 2018 | 2.477M |
| September 30, 2018 | 2.451M |
| June 30, 2018 | 3.125M |
| March 31, 2018 | 1.648M |
| December 31, 2017 | 0.616M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.02M |
| Shareholders Equity (Quarterly) | 4.307M |
| Debt to Equity Ratio | 0.4202 |
| Current Ratio | 1.333 |
| Net Debt Paydown Yield | 7.73% |